Browse articles on EyeWorld.org. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
Cornea Editor Clara Chan, MD, described how innovation, progression, and disruption keep the field evolving and introduced the new Cornea Editor, Julie Schallhorn, MD.
Glaucoma Editor Nathan Radcliffe, MD, spoke about EyeWorld’s approach to glaucoma management and introduced the new Glaucoma Editor, Manjool Shah, MD.
The University of Iowa ophthalmology residents review this article from the May issue of the Journal of Cataract & Refractive Surgery.
The Duke University ophthalmology residents review this article from the July issue of the Journal of Cataract & Refractive Surgery.
While the concept of monovision to enhance distance vision in the dominant eye and provide functional near vision in the non-dominant eye is not new, advances in IOL technologies are providing a more coordinated visual experience compared to prior monovision options.
Still a relatively new technology that is being incorporated into more devices, epithelial mapping use continues to become more widespread among refractive surgeons. From an availability standpoint, Dan Reinstein, MD, who pioneered mapping the epithelium, said “every OCT company is developing or has developed this functionality into their machines.”
For the last decade, interferon alpha-2b was the preferred pharmacologic therapy for ocular surface squamous neoplasia (OSSN) in the U.S. However, with the pandemic, the makers of interferon transitioned its use for treatment of COVID-19 patients instead. This article covers other OSSN treatment options.
While glaucoma specialists are likely familiar with MicroPulse Laser Therapy (Iridex) as a non-incisional, non-pharmaceutical glaucoma therapy, two physicians called it an “ace up your sleeve” and one that can be adopted by any surgeon who treats glaucoma patients.
The December episode of the ASCRS YES Connect Webinar series covers research within a private practice setting. While it might seem that practicing in an academic setting dovetails well with research, Morgan Micheletti, MD, said one shouldn’t discount the amount of research that can be done in private practice.
The FDA issued draft guidance for LASIK patient labeling recommendations in July 2022 that ASCRS and refractive surgeons consider “highly biased and misleading to potential patients.” During the FDA’s comment period, ASCRS submitted these and more specific comments. Last week, the New York Times, CBS, local news outlets, and trade publications picked up the story, but ophthalmologists say most coverage does not convey the whole story.
Get the latest ophthalmology news delivered to your inbox every Friday.